Cite
MLA Citation
Saranya Sridhar et al.. “Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study.” Lancet infectious diseases, vol. 22, no. 5, 2022, pp. 636–648. http://access.bl.uk/ark:/81055/vdc_100153777827.0x00001f